Sara Gianella

Minority variants of drug-resistant HIV.

Detection of minority resistance during early HIV-1 infection: natural variation and spurious detection rather than transmission and evolution of multiple viral variants.

Early antiretroviral therapy during primary HIV-1 infection results in a transient reduction of the viral setpoint upon treatment interruption.

Herpes viruses and HIV-1 drug resistance mutations influence the virologic and immunologic milieu of the male genital tract.

Impact of seminal cytomegalovirus replication on HIV-1 dynamics between blood and semen.

Sexual transmission of predicted CXCR4-tropic HIV-1 likely originating from the source partner's seminal cells.

Role of seminal shedding of herpesviruses in HIV Type 1 Transmission.

Cytomegalovirus DNA in semen and blood is associated with higher levels of proviral HIV DNA.

Highly precise measurement of HIV DNA by droplet digital PCR.

Using ultradeep pyrosequencing to study HIV-1 coreceptor usage in primary and dual infection.

Reply to Mounzer and DiNubile.

Virologic correlates of anti-CMV IgG levels in HIV-1-infected men.

Antibody response to Achromobacter xylosoxidans during HIV infection is associated with lower CD4 levels and increased lymphocyte activation.

Gut Lactobacillales are associated with higher CD4 and less microbial translocation during HIV infection.

HIV migration between blood and cerebrospinal fluid or semen over time.

Estimating the timing of mother-to-child transmission of the human immunodeficiency virus type 1 using a viral molecular evolution model.

Epigenetic alterations in the brain associated with HIV-1 infection and methamphetamine dependence.

Vaginal Cytomegalovirus Shedding Before and After Initiation of Antiretroviral Therapy in Rakai, Uganda.

The Sordid Affair Between Human Herpesvirus and HIV.

Short Communication: Increase of HIV-1 K103N Transmitted Drug Resistance and Its Association with Efavirenz Use in South Korea.

Methamphetamine Use in HIV-infected Individuals Affects T-cell Function and Viral Outcome during Suppressive Antiretroviral Therapy.

CD8 T-Cell Expansion and Inflammation Linked to CMV Coinfection in ART-treated HIV Infection.

Cell-free mitochondrial DNA in CSF is associated with early viral rebound, inflammation, and severity of neurocognitive deficits in HIV infection.

No evidence of posttreatment control after early initiation of antiretroviral therapy.

Circulating HIV DNA Correlates With Neurocognitive Impairment in Older HIV-infected Adults on Suppressive ART.

Genital Epstein Barr Virus is associated with higher prevalence and persistence of anal human papillomavirus in HIV-infected men on antiretroviral therapy.

Signs or Symptoms of Acute HIV Infection in a Cohort Undergoing Community-Based Screening.

Barriers to a cure for HIV in women.

(1→3)-β-D-Glucan Levels Correlate With Neurocognitive Functioning in HIV-Infected Persons on Suppressive Antiretroviral Therapy: A Cohort Study.

Reply to Barrett, et al.

Travel Pattern and Prescription Analysis at a Single Travel Clinic Specialized for Yellow Fever Vaccination in South Korea.

Immunological Signaling During Herpes Simplex Virus-2 and Cytomegalovirus Vaginal Shedding After Initiation of Antiretroviral Treatment.

Quantification of HIV RNA and Human Herpesvirus DNA in Seminal Plasma.

Standard vaccines increase HIV-1 transcription during antiretroviral therapy.

Quantification of Total and 2-LTR (Long terminal repeat) HIV DNA, HIV RNA and Herpesvirus DNA in PBMCs.

Rapid HIV Viral Load Suppression in those Initiating Antiretroviral Therapy at First Visit after HIV Diagnosis.

Cytomegalovirus and HIV: A Dangerous Pas de Deux.

(1→3)-β-d-Glucan: A Biomarker for Microbial Translocation in Individuals with Acute or Early HIV Infection?

Can research at the end of life be a useful tool to advance HIV cure?

Correlation of (1→3)-β-D-glucan with other inflammation markers in chronically HIV infected persons on suppressive antiretroviral therapy.

Increased cell-free mitochondrial DNA is a marker of ongoing inflammation and better neurocognitive function in virologically suppressed HIV-infected individuals.

Early Antiretroviral Therapy Is Associated with Lower HIV DNA Molecular Diversity and Lower Inflammation in Cerebrospinal Fluid but Does Not Prevent the Establishment of Compartmentalized HIV DNA Populations.

Elevated cytomegalovirus IgG antibody levels are associated with HIV-1 disease progression and immune activation.

Evaluation of the Aptima HIV-1 Quant Dx Assay for HIV-1 RNA Quantitation in Different Biological Specimen Types.

No Substantial Evidence for Sexual Transmission of Minority HIV Drug Resistance Mutations in Men Who Have Sex with Men.

Effect of cytomegalovirus and Epstein-Barr virus replication on intestinal mucosal gene expression and microbiome composition of HIV-infected and uninfected individuals.

Sex-based differences in neurocognitive functioning in HIV-infected young adults.

The Importance of Human Immunodeficiency Virus Research for Transgender and Gender-Nonbinary Individuals.

Cytomegalovirus and HIV Persistence: Pouring Gas on the Fire.

Size, Composition, and Evolution of HIV DNA Populations during Early Antiretroviral Therapy and Intensification with Maraviroc.

Ethical considerations for HIV cure-related research at the end of life.

Genital HIV-1 Shedding With Dolutegravir (DTG) Plus Lamivudine (3TC) Dual Therapy.

Soluble Urokinase Plasminogen Activator Receptor Is Predictive of Non-AIDS Events During Antiretroviral Therapy-mediated Viral Suppression.

Metabolic Syndrome and Neurocognitive Deficits in HIV Infection.

Challenges in Quantifying Cytosine Methylation in the HIV Provirus.

Low Rate of Sex-specific Analyses in Presentations at the Conference on Retroviruses and Opportunistic Infections (CROI) Meeting, 2018: Room to Improve.

Soluble suppression of tumorigenicity 2 levels are not predictive of non-AIDS events during antiretroviral therapy-mediated viral suppression.

Plasma (1 → 3)-β-D-glucan and suPAR levels correlate with neurocognitive performance in people living with HIV on antiretroviral therapy: a CHARTER analysis.

I wanted it as soon as possible: a qualitative exploration of reactions to access to same-day ART start among participants in San Diego's ART-NET project.

Presence of Epstein-Barr virus DNA in cerebrospinal fluid is associated with greater HIV RNA and inflammation.

Cytokine Network and Sexual Human Immunodeficiency Virus Transmission in Men Who Have Sex With Men.

HIV persists throughout deep tissues with repopulation from multiple anatomical sources.

Presence of asymptomatic cytomegalovirus and Epstein--Barr virus DNA in blood of persons with HIV starting antiretroviral therapy is associated with non-AIDS clinical events.

Perceptions of Next-of-Kin/Loved Ones About Last Gift Rapid Research Autopsy Study Enrolling People with HIV/AIDS at the End of Life: A Qualitative Interview Study.

"My Death Will Not [Be] in Vain": Testimonials from Last Gift Rapid Research Autopsy Study Participants Living with HIV at the End of Life.

Glucan rich nutrition does not increase gut translocation of beta-glucan.

Sex Differences in CMV Replication and HIV Persistence During Suppressive ART.

Depression in Individuals Coinfected with HIV and HCV Is Associated with Systematic Differences in the Gut Microbiome and Metabolome.

Reduced Independence in Daily Living Is Associated with the Gut Microbiome in People with HIV and HCV.

High Prevalence of HIV-1 Drug Resistance and Dynamics of Transmission Among High-Risk Populations in Port-au-Prince, Haiti.

"[It] is now my responsibility to fulfill that wish:" Clinical and rapid autopsy staff members' experiences and perceptions of HIV reservoir research at the end of life.

Altruism: Scoping review of the literature and future directions for HIV cure-related research.

HIV screening in emergency departments: Linkage works but what about retention?